scholarly article | Q13442814 |
P50 | author | Corinne Arpin | Q42408759 |
P2093 | author name string | C André | |
E Cambau | |||
V Dubois | |||
J Robert | |||
C Quentin | |||
F Grobost | |||
L Coulange | |||
Scientific Committee of ONERBA | |||
P2860 | cites work | Six groups of the OXY beta-Lactamase evolved over millions of years in Klebsiella oxytoca | Q28769512 |
The CTX-M beta-lactamase pandemic. | Q30356558 | ||
Rapid and simple determination of the Escherichia coli phylogenetic group | Q33919655 | ||
Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting. | Q34073299 | ||
CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem | Q34973754 | ||
qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States | Q34973794 | ||
Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes | Q35006613 | ||
Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation | Q35165835 | ||
Molecular epidemiology of TEM-3 (CTX-1) beta-lactamase | Q35248163 | ||
CTX-M beta-lactamase-producing Escherichia coli in French hospitals: prevalence, molecular epidemiology, and risk factors | Q35690509 | ||
Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community | Q36139832 | ||
Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in France | Q36425035 | ||
Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. | Q36598540 | ||
beta-Lactam resistance and beta-lactamases in bacteria of animal origin | Q36738342 | ||
European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis | Q36845365 | ||
Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France | Q36994434 | ||
Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern | Q37091253 | ||
rpoB sequence analysis as a novel basis for bacterial identification | Q38554209 | ||
Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum beta-lactamases in a French hospital | Q39488218 | ||
Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. | Q39664817 | ||
Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. | Q39746711 | ||
Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel | Q39861542 | ||
The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup | Q40003526 | ||
Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers | Q40130533 | ||
Variants of the Klebsiella pneumoniae OKP chromosomal beta-lactamase are divided into two main groups, OKP-A and OKP-B. | Q40668492 | ||
Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii | Q41761814 | ||
Genetic background of Escherichia coli and extended-spectrum beta-lactamase type | Q41916268 | ||
Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. | Q42111230 | ||
Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers | Q42112145 | ||
armA and aminoglycoside resistance in Escherichia coli | Q42184041 | ||
Coexistence of qnrB4 and qnrS1 in a clinical strain of Klebsiella pneumoniae | Q42646339 | ||
Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients | Q44054169 | ||
Effect of D240G substitution in a novel ESBL CTX-M-27. | Q44459209 | ||
Antibiotic resistance rates and phenotypes among isolates of Enterobacteriaceae in French extra-hospital practice | Q44778046 | ||
Citrobacter koseri and Citrobacter amalonaticus isolates carry highly divergent beta-lactamase genes despite having high levels of biochemical similarity and 16S rRNA sequence homology | Q44884984 | ||
Frequency and diversity of Class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective study | Q44999201 | ||
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. | Q45044150 | ||
Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'? | Q46454793 | ||
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. | Q46852401 | ||
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases | Q46956002 | ||
Detection of a novel variant bla(CTX-M-3) extended spectrum beta-lactamase gene in a community-acquired Escherichia coli isolate | Q46962910 | ||
The identification of CTX-M-14, TEM-52, and CMY-1 enzymes in Escherichia coli isolated from the Han River in Korea. | Q54414663 | ||
Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. | Q54454379 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Enterobacteriaceae | Q380136 |
P304 | page(s) | 1205-1214 | |
P577 | publication date | 2009-03-28 | |
P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
P1476 | title | Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting | |
P478 | volume | 63 |
Q87584656 | Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae |
Q30567915 | Antibacterial resistances in uncomplicated urinary tract infections in women: ECO·SENS II data from primary health care in Austria |
Q38970658 | Clinical and microbiological determinants of severe and fatal outcomes in patients infected with Enterobacteriaceae producing extended-spectrum β-lactamase. |
Q64246611 | Clinical outcome of bloodstream infection in cancer patients with/without biofilm formation: a single-center retrospective study |
Q57821217 | Community-Acquired Urinary Tract Infection by in the Era of Antibiotic Resistance |
Q41893419 | Comparison of five media for detection of extended-spectrum Beta-lactamase by use of the wasp instrument for automated specimen processing |
Q36969909 | Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trend |
Q30389929 | Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study |
Q34027016 | Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008 |
Q28073332 | Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis |
Q30396308 | Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain |
Q34057648 | Escherichia coli ST131, an intriguing clonal group |
Q38201515 | Escherichia coli sequence type 131: epidemiology and challenges in treatment. |
Q35806283 | Evolution of an incompatibility group IncA/C plasmid harboring blaCMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit |
Q42225322 | Extended-spectrum β-lactamase-producing Enterobacteriaceae in French nursing homes: an association between high carriage rate among residents, environmental contamination, poor conformity with good hygiene practice, and putative resident-to-resident |
Q40569488 | Extended-spectrum β-lactamase-producing bacteria caused less than 5% of urinary tract infections in a paediatric emergency centre. |
Q54379577 | Fecal carriage of third-generation cephalosporins-resistant Enterobacteriaceae in asymptomatic young adults: evolution between 1999 and 2009 |
Q37413795 | High Prevalence of ESBL-Producing Klebsiella pneumoniae Causing Community-Onset Infections in China. |
Q58730452 | In Vitro Activity of Newer and Conventional Antimicrobial Agents, Including Fosfomycin and Colistin, against Selected Gram-Negative Bacilli in Kuwait |
Q43589685 | In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany |
Q37694529 | Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices |
Q37603196 | Lauryl-poly-L-lysine: A New Antimicrobial Agent? |
Q92890652 | Lipid oligonucleotides as a new strategy for tackling the antibiotic resistance |
Q46986700 | Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings |
Q43189985 | Low frequency of antibiotic resistance among urine isolates of Escherichia coli in the community, despite a major hospital outbreak with Klebsiella pneumoniae producing CTX-M-15 in Uppsala County |
Q57031890 | Molecular characterization, antimicrobial resistance and clinico-bioinformatics approaches to address the problem of extended-spectrum β-lactamase-producing Escherichia coli in western Saudi Arabia |
Q24633808 | Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmid |
Q34694361 | Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals |
Q37735903 | Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance |
Q35815939 | Occurrence of CTX-M Producing Escherichia coli in Soils, Cattle, and Farm Environment in France (Burgundy Region). |
Q43360031 | Persistence and prevalence of pathogenic and extended-spectrum beta-lactamase-producing Escherichia coli in municipal wastewater treatment plant receiving slaughterhouse wastewater. |
Q45711115 | Piperacillin-tazobactam as alternative to carbapenems for ICU patients |
Q35228750 | Prevalence and characteristics of extended-spectrum β-lactamase and plasmid-mediated fluoroquinolone resistance genes in Escherichia coli isolated from chickens in Anhui province, China |
Q36945809 | Prevalence of CTX-M-Type and PER Extended-Spectrum β-Lactamases Among Klebsiella spp. Isolated From Clinical Specimens in the Teaching Hospital of Kashan, Iran |
Q60938096 | Recent advances in managing lower urinary tract infections |
Q40014484 | Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae |
Q36061308 | Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe |
Q38497797 | The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae |
Q54322788 | [Urinary tract infection with Escherichia coli producing extended-spectrum β-lactamase in a traveler returning from Southeast Asia]. |
Search more.